Structures by: Sava G.
Total: 11
P-CymRuCl2(anthraimid)
C68H58BClN4Ru
Journal of medicinal chemistry (2007) 50, 9 2166-2175
a=10.6994(5)Å b=29.8522(17)Å c=18.8571(10)Å
α=90.00° β=116.835(4)° γ=90.00°
[p-CymRuCl(anthraimid)2]BPh4
C27H26Cl2N2Ru
Journal of medicinal chemistry (2007) 50, 9 2166-2175
a=14.340(2)Å b=12.4234(15)Å c=15.1560(17)Å
α=90.00° β=117.502(9)° γ=90.00°
P-CymRuCl2(phenoxbenzimid).EtOAc
C35H37Cl2N3O4Ru
Journal of medicinal chemistry (2007) 50, 9 2166-2175
a=12.658(3)Å b=14.916(5)Å c=17.958(4)Å
α=90.00° β=102.445(18)° γ=90.00°
C24H20B,C12H14ClN4Ru
C24H20B,C12H14ClN4Ru
Journal of medicinal chemistry (2006) 49, 18 5552-5561
a=13.3895(17)Å b=12.5339(9)Å c=18.671(2)Å
α=90.00° β=104.039(9)° γ=90.00°
(p-Cym)Ru(N-ImMe)2Cl.H2O
C18H26ClN4Ru,H2O,Cl
Journal of medicinal chemistry (2006) 49, 18 5552-5561
a=7.8903(6)Å b=9.5995(3)Å c=14.1039(5)Å
α=78.964(3)° β=87.859(4)° γ=86.905(4)°
[Ru(p-cymene)(bimid)2Cl]Cl
C24H38ClN4Ru,Cl
Journal of medicinal chemistry (2006) 49, 18 5552-5561
a=8.563(7)Å b=13.044(11)Å c=13.243(3)Å
α=110.87(3)° β=98.93(4)° γ=95.91(6)°
C18H24N6Ru,2(BF4)
C18H24N6Ru,2(BF4)
Journal of medicinal chemistry (2006) 49, 18 5552-5561
a=8.4268(4)Å b=13.5307(8)Å c=19.9593(11)Å
α=90.00° β=91.305(4)° γ=90.00°
C24H38ClN4Ru,C10H14Cl3Ru
C24H38ClN4Ru,C10H14Cl3Ru
Journal of medicinal chemistry (2006) 49, 18 5552-5561
a=12.4321(10)Å b=12.9605(11)Å c=13.0867(13)Å
α=90.149(8)° β=117.791(6)° γ=90.948(6)°
C34H41ClN3P2Ru,BF4
C34H41ClN3P2Ru,BF4
Dalton transactions (Cambridge, England : 2003) (2007) 43 5065-5072
a=13.6698(10)Å b=14.4658(9)Å c=17.1533(6)Å
α=90.00° β=99.576(5)° γ=90.00°
[RuCl(Me5Cp)(C6H12N3)2]
C24H43Cl3N6P2Rux
Chemical communications (Cambridge, England) (2003)
a=12.5986(2)Å b=16.2139(3)Å c=16.3454(3)Å
α=64.0661(8)° β=82.934(1)° γ=80.159(1)°
C14H25BClF4N4OPRu
C14H25BClF4N4OPRu
Organometallics (2006) 25, 3 756
a=11.1961(10)Å b=14.3501(13)Å c=12.3751(11)Å
α=90.00° β=103.432(8)° γ=90.00°